Journal of Otorhinolaryngology and Facial Plastic Surgery

Vol. 6 No. 1 (2020)

Olfactory and gustatory manifestations in hospitalized patients with COVID-19

Journal of Otorhinolaryngology and Facial Plastic Surgery, Vol. 6 No. 1 (2020), 12 September 2020 , Page 1-7
https://doi.org/10.22037/orlfps.v6i1.33962

Abstract

Background: Pulmonary involvement is the main clinical and imaging feature of the novel corona virus disease (COVID-19). However, some patients present with upper airway symptoms.

Aim: In this study, we report upper respiratory manifestations, specifically focusing on smell and taste disorders in COVID-19.

Methods: We performed this cross-sectional prospective study in patients admitted to Masih Daneshvari Hospital, a tertiary referral center in Tehran, Iran, with severe COVID-19 as documented by the polymerase chain reaction assay.

Results: We included 268 hospitalized patients, 183 (68.3%) men and 85 (31.7%) women. The average age was 52.8±16.4. The sinonasal symptoms included nasal obstruction (44 [16.4%]), rhinorrhea (31 [11.5%]), sneeze (33 [12.3%]), headache (77 [28.6%]), facial pain (12 [4.5%]), associated with hypogeusia (65 [24.2%]) and olfactory dysfunction (90 [33.5%]). In 35 (38.9%) patients with olfactory symptoms, change in the smell was the sole initial manifestation of COVID-19. On logistic regression, the relationship between the olfactory symptoms and headache (p=0.002), nasal obstruction (p=0.0001) and sneeze (p=0.018) were statistically significant.

Conclusion: We report a considerable prevalence of olfactory and gustatory symptoms in hospitalized patients with COVID-19. Not infrequently, these symptoms were the sole initial presenting symptoms in the course COVID-19. During the current pandemic, we suggest that presence of these symptoms should mandate expedited screening for COVID-19, isolation and close monitoring of the patients for evolution of the clinical course.

Keywords:
  • COVID-19; Olfactory manifestations; Gustatory manifestations

How to Cite

Safavi Naini, A., Karimi-Galougahi, M. ., Ghorbani, J. ., Raad, N. ., & Tabarsi, P. . (2020). Olfactory and gustatory manifestations in hospitalized patients with COVID-19. Journal of Otorhinolaryngology and Facial Plastic Surgery, 6(1), 1–7. https://doi.org/10.22037/orlfps.v6i1.33962

References

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020 Jan 24. doi: 10.1056/NEJMoa2001017
2. WHO. Coronavirus disease 2019 (COVID-19) Situation Report-32. January 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports
3. Richman DD, Whitley RJ, Hayden FG. Clinical virology, 4th Edition. ASM Press, Washington; 2016.
4. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature. 2020 Mar;579(7798):270-3. doi: 10.1038/s41586-020-2012-7.
5. Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infection, Genetics and Evolution 2020; 79: 104212.doi: 10.1016/j.meegid.2020.104212.
6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med 2020 ;382(18):1708-20. doi: 10.1056/NEJMoa2002032
7. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al .Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 ;277(8):2251-61. doi: 10.1007/s00405-020-05965-1
8. Cho s. Clinical Diagnosis and Treatment of Olfactory Dysfunction. Hanyang Med Rev 2014; 34:107–15. http://dx.doi.org/10.7599/hmr.2014.34.3.107
9. Seiden A. Postviral olfactory loss. Otolaryngol Clin N Am 2004; 37(6): 1159–1166 doi: 10.1016/j.otc.2004.06.007.
10. Welge-Lussen A. Re-establishment of Olfactory and Taste Functions. GMS Curr Top Otorhinolaryngol Head Neck Surg 2005; 4: Doc06
11. Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H,,et al. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope 2007; 117(2):272–7. doi:10.1097/01.mlg.0000249922.37381.1e
12. Passioti M, Maggina P, Megremis S, Papadopoulos NG. The common cold: potential for future prevention or cure. Curr Allergy Asthma Rep 2014; 14(2): 413 .doi :10.1007/s11882-013-0413-5
13. Wrobel BB, Leopold DA. Clinical assessment of patients with smell and taste disorders. Otolaryngol Clin N Am 2004; 37(6): 1127–42. doi: 10.1016/j.otc.2004.06.010
14. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al. Clinical progression of patients with COVID-19 in Shanghai, China. Journal of Infection 2020;80(5):e1-e6.doi.org/10.1016/j.jinf.2020.03.004
15. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. doi.org/10.1016/ S0140-6736 (20) 30183-5
16. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061–1069. doi: 10.1001/jama.2020.1585.
17. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507–13.doi.org/10.1016/S0140-6736 (20) 30211-7
18. Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging.2020;47(5):1275-80. doi:10.1007/s00259-020-04735-9
19. Mao L,Jin H, Wang M. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Neurol 2020 Apr 10;e201127. doi:10.1001/jamaneurol.2020.1127.
20. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol 2020;1–4. doi: 10.1002/jmv.25728
21. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82(15):7264–75. doi: 10.1128/JVI.00737-08
22. Hwang CS. Olfactory Neuropathy in Severe Acute Respiratory Syndrome:Report of A Case. Acta Neurol Taiwan 2006;15 26-8.
23. Schwob J, Saha S, Youngentob SL, Jubelt B. Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in olfactory epithelium of mice. Chem Senses 2001;26:937–52.
24. doi: 10.1093/chemse/26.8.937.
24- Li K, Wohlford-Lenane C, Perlman S, Zhao J, Jewell AK, Reznikov LR, et al. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis 2016;213:712–22 .doi: 10.1093/infdis/jiv499
  • Abstract Viewed: 263 times
  • PDF Downloaded: 309 times

Download Statastics

Information